Robert Slany
Hat mitgewirkt an:
-
MLL-Fusionsproteine in Leukämien : Analyse eines neuen onkogenen Wirkungsprinzips
-
Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia
-
Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia